Cargando…
Towards subsidized malaria rapid diagnostic tests. Lessons learned from programmes to subsidise artemisinin-based combination therapies in the private sector: a review
The idea of a private sector subsidy programme of artemisinin-based combination therapies (ACTs) was first proposed in 2004. Since then, several countries around the world have hosted pilot projects or programmes on subsidized ACTs and/or the Affordable Medicines Facility-malaria programme (AMFm). O...
Autor principal: | Lussiana, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977424/ https://www.ncbi.nlm.nih.gov/pubmed/25862732 http://dx.doi.org/10.1093/heapol/czv028 |
Ejemplares similares
-
Subsidising artemisinin‐based combination therapy in the private retail sector
por: Opiyo, Newton, et al.
Publicado: (2016) -
Modelling the cost-effectiveness of introducing subsidised malaria rapid diagnostic tests in the private retail sector in sub-Saharan Africa
por: Bath, David, et al.
Publicado: (2020) -
Changes in the availability and affordability of subsidised artemisinin combination therapy in the private drug retail sector in rural Ghana: before and after the introduction of the AMFm subsidy
por: Ansah, Evelyn K., et al.
Publicado: (2016) -
Quality issues with malaria rapid diagnostic test accessories and buffer packaging: findings from a 5-country private sector project in Africa
por: Harvey, Steven A., et al.
Publicado: (2017) -
The private sector market for malaria rapid diagnostic tests in Nigeria: results of the 2018 market survey
por: Edwards, Hannah M., et al.
Publicado: (2022)